T Cell–specific Inactivation of the Interleukin 10 Gene in Mice Results in Enhanced T Cell Responses but Normal Innate Responses to Lipopolysaccharide or Skin Irritation by Roers, Axel et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
 
J. Exp. Med. 
 
©
 
 The Rockefeller University Press • 0022-1007/2004/11/1289/9 $8.00
Volume 200, Number 10, November 15, 2004 1289–1297
http://www.jem.org/cgi/doi/10.1084/jem.20041789
 
1289
 
T Cell–speciﬁc Inactivation of the Interleukin 10 Gene in 
Mice Results in Enhanced T Cell Responses but Normal 
Innate Responses to Lipopolysaccharide or Skin Irritation
 
Axel Roers,
 
1 
 
Lisa Siewe,
 
1 
 
Elke Strittmatter,
 
1 
 
Martina Deckert,
 
2 
 
Dirk Schlüter,
 
3,4 
 
Werner Stenzel,
 
2 
 
Achim D. Gruber,
 
5 
 
Thomas Krieg,
 
1 
 
Klaus Rajewsky,
 
6 
 
and Werner Müller
 
7
 
1
 
Department of Dermatology and 
 
2
 
Department of Neuropathology, University of Cologne, 50931 Cologne, Germany
 
3
 
Institut für Medizinische Mikrobiologie,Otto-von-Guericke Universität Magdeburg, D-39120 Magdeburg, Germany
 
4
 
Department of Medical Microbiology and Hygiene, University Hospital Mannheim, University of Heidelberg, 
D-68167 Mannheim, Germany
 
5
 
Department of Pathology, School of Veterinary Medicine Hannover, D-30559 Hannover, Germany
 
6
 
Center for Blood Research, Harvard Medical School, Boston, MA 02115
 
7
 
Department of Experimental Immunology, German Research Center for Biotechnology, D-38124 
Braunschweig, Germany
 
Abstract
 
Interleukin (IL)-10 is a regulator of inflammatory responses and is secreted by a variety of different
cell types including T cells. T regulatory cells have been shown to suppress immune responses
by IL-10–dependent, but also IL-10–independent, mechanisms. Herein, we address the role of
T cell–derived IL-10 in mice with an inactivation of the 
 
IL-10
 
 gene restricted to T cells generated
by Cre/loxP-mediated targeting of the 
 
IL-10
 
 gene. Splenocytes from this T cell–specific mutant
secrete increased amounts of proinflammatory cytokines after activation in vitro compared with
show enhanced contact hypersensitivity reactions, and succumb to severe immunopathology
upon infection with 
 
Toxoplasma gondii
 
. Despite intact 
 
IL-10
 
 genes in other cell types, the dys-
regulation of T cell responses observed in the T cell–specific 
 
IL-10
 
 mutant closely resembles
the phenotype in complete IL-10 deficiency. However, in contrast to complete IL-10 defi-
ciency, sensitivity to endotoxic shock and irritant responses of the skin are not enhanced in the
T cell–specific 
 
IL-10
 
 mutant. Our data highlight the importance of T cell–derived IL-10 in the
regulation of T cell responses and demonstrate that endotoxic shock and the irritant response of
the skin are controlled by IL-10 from other cell types.
Key words: cytokines • gene targeting • inﬂammation • inﬂammatory bowel disease • 
allergic contact dermatitis
 
Introduction
 
IL-10 is a regulator of inflammatory responses that limits
damage to host tissue by effectors of the immune system in
the course of responses to microbial pathogens (1). By inhib-
iting the activation of macrophages, IL-10 controls responses
of the innate immune system. Furthermore, effects of IL-10
on antigen-presenting cells as well as direct suppressive effects
on T cells modulate T cell responses by inhibiting Th1 cell
differentiation and action (1). IL-10–deficient (
 
IL-10
 
 
 
/
 
 
 
)
mice mount exaggerated Th1 cell responses and spontane-
ously develop inflammatory bowel disease (IBD) as a result
of an unbalanced response to environmental antigens (2).
They also exhibit increased susceptibility to immunopathology
upon parasitic and bacterial infection (3–6) or LPS exposure
(7), as well as enhanced contact hypersensitivity reactions
and irritant responses of the skin (8).
Originally identified as a Th2 cell–derived factor (9), IL-10
was later found to be secreted by a variety of haemopoietic
cell types including activated macrophages (10, 11), den-
dritic cells (12–15), B cells (16–18), and mast cells (19). In
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addition, keratinocytes can be induced to secrete IL-10 by
contact allergens (20) or UV irradiation (21). Human intes-
tinal epithelial cells were reported to constitutively secrete
the cytokine (22).
Over the past few years, a number of different T cell
subsets were identified as important regulators of immune
responses (23, 24). The lack of the best characterized subset
of regulatory T cells, the CD4
 
  
 
CD25
 
  
 
cells, in mice defi-
cient for the transcription factor foxp3 results in severe in-
flammatory multiorgan disease (25–27). In IL-10–deficient
mice, functionally active CD4
 
  
 
CD25
 
  
 
regulatory T cells
are present (28) and in comparison to foxp3-deficient mice,
 
IL-10
 
 
 
/
 
  
 
animals develop a less severe disease with a later
onset. IL-10–dependent, but also IL-10–independent, sup-
pressive effects mediated by regulatory T cells have been
described in a variety of experimental systems (28–32).
Thus, the relevance of T cell–derived IL-10 in the regula-
tion of immune responses remains unclear.
To determine the role of T cell–derived IL-10 in vivo, we
generated mice with a selective deficiency for IL-10 only in
T cells by Cre/loxP-mediated gene targeting and compared
T cell and innate immune responses of these animals to re-
sponses of mice with complete IL-10 deficiency. We found
that although T cell responses were similarly enhanced in
mice with T cell–specific or complete IL-10 deficiency in
comparison to control animals, innate responses to LPS or ir-
ritation of the skin were deregulated under the condition of
complete, but not in T cell–specific, IL-10 deficiency.
 
Materials and Methods
 
Gene Targeting.
 
The targeting vector was constructed by
cloning two genomic fragments of the murine 
 
IL-10
 
 gene (long
and short arm of homology) into plasmid peasy flox (provided by
M. Alimzhanov, Harvard Medical School, Boston, MA) after a
loxP site along with an additional PstI restriction site had been
inserted into the long arm of homology. The linearized construct
was transfected into Ola129-derived embryonic stem cells (IB-
10). Homologous recombinants were analyzed for single copy in-
tegration of the targeting vector by Southern blot analysis and
were transfected with ppgk-Cre for Cre-mediated deletion of the
neomycin selection marker in vitro. Clones carrying the 
 
IL-10
 
FL
 
mutation were injected into CB20 blastocysts, which were then
implanted into foster mothers. Chimeric offspring were mated to
C57BL/6 mice and the F1 generation was screened for germline
transmission of the mutation. Mice were kept in a specific patho-
gen-free facility. 
 
IL-10
 
FL 
 
mice were crossed to C57BL/6 deleter
Cre mice (33) and to CD4-Cre mice (34) on a mixed C57BL/
6-DBA/2-129v/J background. All animal experimentation was
performed in accordance with institutional guidelines.
 
Genotyping.
 
Tail DNA samples were digested with PstI.
Southern blots were hybridized with probe 3 for detection of 
 
IL-
10
 
 alleles and probe 10 for detection of Cre transgenes using the
Gene Images CDP-Star random prime labeling and detection
modules (Amersham Biosciences) according to the manufac-
turer’s instructions. For radioactive hybridization, the Laderman
labeling kit (TaKaRa) was used to label probe DNA and hybrid-
ization was performed in QuikHyb Hybridization Solution (Strata-
gene). Primers for amplification of probes were probe3up (5
 
  
 
aca
gac tag aca gga gac tag gta a), probe3do (5
 
  
 
c agc aga gga cag cct
aga aag atg), CreC1 (5
 
  
 
caa ttt act gac cgt aca c), and CreDo (5
 
 
 
gtt ttg cac gtt cac cgg cat caa).
 
Cell Sorting.
 
Spleen cell suspensions were subjected to eryth-
rocyte lysis and Ficoll-Paque (Amersham Biosciences) gradient
centrifugation for depletion of residual erythrocytes and dead
cells. T cells, B cells, and dendritic cells were enriched immuno-
magnetically using CD3, CD19, and CD11c microbeads (Mil-
tenyi Biotec), respectively, and then were sorted from the enriched
suspensions after immunostaining for CD3, CD19, and CD11c
(BD Biosciences) on a FACStar (BD Biosciences). Macrophages
were isolated from peritoneal lavage fluid by FACS sorting of F4/
80-stained (Serotec) cells.
 
Splenocyte Stimulation and Cytokine Quantification.
 
96-well plates
were antibody coated by incubation for 90 min at 37
 
 
 
C with a
solution of 10 
 
 
 
g/ml anti-CD3 (clone 145-2C11; BD Bio-
sciences) and 5 
 
 
 
g/ml anti-CD28 (clone 37.51; BD Biosciences)
antibodies in PBS. Splenocyte suspensions were depleted of
erythrocytes and dead cells by Ficoll-Paque gradient centrifuga-
tion (Amersham Biosciences) before addition to coated 96 wells
in a density of 10
 
6 
 
cells/ml. Culture supernatants were harvested
after 48 h. Measurement of cytokine concentrations in culture
supernatants was performed by Cytometric Bead Array (BD Bio-
sciences) according to the manufacturer’s instructions.
 
Toxoplasma Infection. IL-10
 
FL/FL 
 
CD4-Cre
 
  
 
and Cre
 
  
 
control
mice were infected orally with the low virulence DX strain of
Figure 1. Conditional targeting of the IL-10 gene. (A) Scheme show-
ing the WT IL-10 genomic locus (WT) and the mutant IL-10 alleles after
homologous recombination of the targeting vector (Neo), after Cre-
mediated deletion of the neomycin resistance gene (FL), and after Cre-
mediated deletion of the loxP-flanked promoter region and exon1 (D).
The location of the probe for Southern blot analysis as well as restriction
enzyme sites (P, PstI) are indicated. PstI fragments are in kilobases (kb). Filled
boxes represent exons. LoxP sites are depicted as arrowheads. (B) Southern
blot analysis of DNA from tail biopsies from a WT, an IL-10FL/FL, and an
IL-10D/D mouse. 
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Toxoplasma gondii
 
 as described previously (35). Animals were
killed on days 7 and 10 after injection and liver tissue was snap-
frozen in liquid nitrogen or fixed and paraffin embedded. Immu-
nohistochemistry was performed on 10-
 
 
 
m cryostat sections.
CD4, CD8, CD45, B220, F4/80, and 
 
T. gondii
 
 antigens were de-
tected as described previously (35).
 
Contact Hypersensitivity Reaction and Irritant Response.
 
Con-
tact hypersensitivity was induced by painting the shaved abdomen
with 100 
 
 
 
l of 5% (wt/vol) 2,4-dinitrochlorobenzene (DNCB;
Sigma-Aldrich) in a 4:1 mixture of acetone and olive oil for sensi-
tization. The mice were challenged 6 d later by application of 10
 
 
 
l of 1% (wt/vol) DNCB in olive oil to each side of one ear. Ear
thickness was determined before challenge and daily thereafter for
4 d using an engineer’s caliper (Mitutoyo). Percent increase of ear
thickness was compared for the different experimental groups us-
ing the student’s 
 
t 
 
test for independent samples. The irritant re-
sponse was elicited by applying 20 
 
 
 
l of 1% (vol/vol) Croton oil
(Sigma-Aldrich) in acetone to one ear, 10 
 
 
 
l to each side of the
ear. Ear thickness was measured before as well as 24 and 48 h after
irritant application and evaluated as described above.
 
LPS Sensitivity.
 
The response to LPS (LPS from 
 
Escherichia
coli
 
 serotype 055:B5; Sigma-Aldrich) was tested by a single i.p. in-
jection of 20 
 
 
 
g/g body weight in 200 
 
 
 
l sterile saline. Survival
was monitored for 5 d thereafter. In additional animals, blood
samples were taken 6 h after LPS injection and assayed for serum
TNF-
 
 
 
, IFN-
 
 
 
, and IL-12 p70 concentrations by a cytometric
bead array kit (BD Biosciences).
 
Results
 
Conditional Mutagenesis of the IL-10 Gene.
 
We gener-
ated mice with an 
 
IL-10
 
 allele mutated by the insertion of
two loxP sites flanking parts of the promoter region, tran-
scription initiation site, and the first exon (Fig. 1, floxed al-
lele). 
 
IL-10
 
FL/FL 
 
mice develop normally, are fertile, and do
not show any sign of IBD macroscopically or histologically
(
 
n 
 
  
 
5; not depicted), indicating that the insertion of the
loxP sites does not significantly interfere with regulation of
the 
 
IL-10
 
 gene. Crossing of 
 
IL-10
 
FL/FL 
 
mice to a Cre trans-
genic strain expressing Cre recombinase ubiquitously in
early stages of ontogeny (33) yielded mice carrying deleted
alleles in all cell types (
 
IL-10
 
D/D
 
). As expected, these ani-
mals exhibited IBD, enhanced contact hypersensitivity and
irritant reactions, as well as increased sensitivity to LPS (see
below). 
 
IL-10
 
D/D 
 
mice thus reproduce the phenotype of
conventional IL-10–deficient mice (2), which indicates that
as intended, Cre-mediated deletion of the loxP-flanked
fragment inactivates the 
 
IL-10
 
 gene.
 
T Cell–specific Inactivation of the IL-10 Gene. IL-10
 
FL
 
mice were crossed to a transgenic line expressing Cre under
the control of the murine CD4 enhancer/promoter/silencer,
Figure 2. T cell–specific deletion of the IL-10 gene in IL-10FL/FL
CD4-Cre  mice. Southern blot analysis of DNA extracted from different
FACS-sorted cell populations and tissues after PstI digest. (A) CD3  T
and CD19  B cells sorted to a purity of 98 and 96%, respectively, from
splenocyte suspension of a 3-mo-old mouse. The result is representative
of five animals. (B) F4/80  macrophages from peritoneal lavage fluid (purity
97%, representative of four animals) and splenic T cells. (C) Splenic
CD11c  dendritic cells sorted to a purity of 95% (representative of three
animals) and splenic T cells. (D) Various tissues and splenic T cells from
an 8-wk-old mouse.
Figure 3. Cytokine and chemokine secretion by splenocytes from mice
with complete or T cell–specific IL-10 deficiency after stimulation by
plate-bound anti-CD3 and anti-CD28 antibodies in vitro. (A) Concen-
trations of IFN- , TNF- , IL-12, IL-6, and MCP-1 in 48-h culture su-
pernatants of splenocytes from IL-10FL/FL CD4-Cre  animals (n   9;  ,
unstimulated;  , stimulated), IL-10FL/FL Cre  controls (n   8;  , unstim-
ulated;  , stimulated), and (B) in supernatants of splenocyte cultures from
IL-10D/D animals (n   5;  , unstimulated;  , stimulated) and IL-10WT/D
controls (n   5;  , unstimulated;  , stimulated). 
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which results in high efficiency Cre-mediated deletion com-
mencing in CD4  CD8  (double positive) progenitors of
CD4 and CD8 lymphocytes (CD4-Cre transgenic mice; ref-
erences 34 and 36). The efficiency and T cell specificity of
Cre-mediated deletion was verified by Southern blot anal-
ysis of DNA extracted from FACS-sorted cell populations.
Complete deletion of the loxP-flanked fragment was found
in CD3  T cells from the spleens of IL-10FL/FL CD4-Cre 
mice (Fig. 2 A). In contrast, no deletion was observed in
CD19  splenic B cells (Fig. 2 A), in peritoneal macrophages
(Fig. 2 B), or in CD11c  splenic dendritic cells (Fig. 2 C). In
addition, DNA extracted from the brain, heart, lung, thy-
mus, liver, muscle, kidney, and tail tissue was analyzed for
deletion of the loxP-flanked fragment by Southern blot hy-
bridization (Fig. 2 D). The degree to which deletion oc-
curred corresponded with the number of resident and
blood-borne T cells expected to be contained in these tis-
sues. Thus, inactivation of the IL-10 gene in IL-10FL/FL
CD4-Cre  mice is efficient in T cells and was not detected
in other cell types by Southern blot analysis. Peritoneal mac-
rophages from IL-10FL/FL CD4-Cre  mice secreted similar
amounts of IL-10, as did macrophages from control animals
after stimulation with LPS in vitro (not depicted).
Enhanced Secretion of Proinflammatory Cytokines by Spleno-
cytes from T Cell–specific IL-10 Mutants. To compare cyto-
kine production in mice with T cell–specific or complete
IL-10 deficiency, we stimulated IL-10FL/FL CD4-Cre  and
Cre  as well as IL-10D/D and IL-10D/WT spleen cells with
anti-CD3 and anti-CD28 antibodies in vitro. The IL-10FL/FL
CD4-Cre  animals analyzed all displayed rectal prolapse
by the time of the experiment, indicating with high proba-
bility the presence of intestinal inflammation (see below).
TNF-  levels of culture supernatants from stimulated IL-
10FL/FL CD4-Cre  splenocytes were on average three times
higher than those of control cultures from Cre  animals
(Fig. 3 A). Similar results were obtained for the TNF- –
induced chemokine monocyte chemoattractant protein 1
(MCP-1) and IL-6. IFN-  concentrations were similar in
stimulated Cre  and Cre  cultures. IL-12 levels of five
stimulated Cre  cultures were in the same range as those in
Cre  cultures. Four cultures reached concentrations that
were three- to sevenfold higher. IL-10 was secreted in very
low or undetectable amounts not different for Cre  versus
Cre  cells (not depicted). These results demonstrate that T
cell responses in IL-10FL/FL CD4-Cre  mice are accompa-
nied by increased secretion of inflammatory mediators.
Four additional IL-10FL/FL CD4-Cre  animals analyzed did
not show rectal prolapse and were thus probably devoid of
IBD. Interestingly, secretion of cytokines released by sple-
nocytes from these four animals after T cell stimulation was
similar to that of splenocytes from Cre  controls or was
only moderately increased (not depicted).
The increased production of proinflammatory mediators
by cells from T cell–specific mutant mice in vitro was similar
to the results obtained for IL-10D/D mice (Fig. 3 B). In accor-
dance with published experiments with IL-10 /  mice (2),
Figure 4. (A) Histology of colonic mucosa. Note massive hyperplasia
and edema of the mucosa in the T cell–specific IL-10 mutant. Paraffin
sections, hematoxylin and eosin stain. Bar, 40  m. (B) Cumulative incidence
of rectal prolapse indicating severe intestinal inflammation in IL-10D/D mice
( , n   90) and IL-10FL/FL CD4-Cre  mice ( , n   142).Roers et al. 1293
secretion of IFN- , TNF- , IL-6, and MCP-1 by stimu-
lated splenocytes from IL-10D/D mice was clearly increased in
comparison with cell suspensions from control animals.
T Cell–specific IL-10 Mutants Spontaneously Develop IBD.
IL-10FL/FL  CD4-Cre   and  IL-10D/D  were kept under
standard specific pathogen-free conditions. A fraction
of IL-10FL/FL CD4-Cre  mice developed rectal prolapse,
which is an indicator of severe intestinal inflammation in
mice. Histologically, the most prominent inflammatory
changes were found in the cecum and ascending colon
(Fig. 4 A), where multifocal severe inflammation affected
all strata of the colonic wall, in some animals including the
serosa with consecutive peritonitis. Multifocal mucosal
necroses resulted in numerous ulcerations. The mucosa
showed massive hyperplasia and infiltration with inflamma-
tory cells, ectatic lymphatic vessels, and crypt abscesses. In
addition to these focal changes, there was diffuse infiltra-
tion of the colonic mucosa with neutrophils, lymphocytes,
plasma cells, and macrophages. Lympho-plasmocytic inflam-
mation with focally hyperplastic mucosa was also found in
duodenum and rectum, although it was less prominent in
these locations. All animals that displayed the histologic
changes described above (n   9) also had macroscopically
evident prolapse of the rectal mucosa. In IL-10FL/FL CD4-
Cre  mice without prolapse (n   6), we did not find signs
of IBD histologically. The earliest occurrence of rectal pro-
lapse was at the age of 4 wk. The incidence of bowel dis-
ease in the T cell–specific IL-10 mutants increased with
age, reaching 33% at 6 mo (Fig. 4 B).
Intestinal inflammation in the T cell–specific IL-10 mu-
tant mice closely resembled IBD in IL-10 /  mice (2) or IL-
10D/D animals with complete IL-10 deficiency with respect
to incidence, localization, and severity. The incidence of
IBD in IL-10D/D mice was 41% at the age of 6 mo (Fig. 4 B).
In RNA samples from the cecum of WT as well as
healthy or diseased T cell–specific mutant mice, but not
from IL-10D/D mice, we detected IL-10 mRNA by RT-
PCR (not depicted). These data suggest that there is IL-10
production from non–T cells in the T cell–specific mutant
animals. However, IL-10 secretion from cell types other
than T cells does not prevent intestinal inflammation.
All animals were kept in a facility that was specific
pathogen-free except for a high prevalence of infection
with Helicobacter ganmani (37) as detected by PCR and se-
quencing. Although some Helicobacter species are known
to exacerbate IBD in susceptible animals (38), this has not
been described for H. ganmani. Thus, we can only speculate
that H. ganmani infection may enhance intestinal inflamma-
tion in our mutant mice.
T Cell–specific IL-10 Mutants Succumb to Infection with T.
gondii. To further characterize immune reactions in the T
cell–specific IL-10 mutant animals, we infected IL-10FL/FL
CD4-Cre  mice orally with a low virulence strain of T.
gondii. All seven mutants succumbed by 11 d after infec-
tion, whereas none of the eight Cre  control animals de-
veloped disease (Fig. 5 A). Death was associated with
severe hepatitis characterized by disseminated focal inflam-
matory infiltrates (Fig. 5 B, top), whereas only mild hepati-
tis was detected in the controls (n   5). In the mutants, nu-
merous CD4  T cells were detected in the liver by day 7
after infection (Fig. 5 B, bottom), with numbers increasing
until day 10 (not depicted), whereas the scarce infiltrates in
the livers of control mice contained only low numbers
of CD4  T cells at both time points. There were no differ-
Figure 5. Infection of T cell–specific IL-10 mutants with T. gondii. (A) Survival of IL-10FL/FL CD4-Cre  mice (n   7) and IL-10FL/FL Cre  control
animals (n   8). Two and three mutants were killed because of severe, overt disease on days 7 and 10 after infection, respectively. Two and three control
mice, which never showed symptoms or signs of disease, were killed in parallel on days 7 and 10, respectively. Three controls were killed 10 wk after
infection. (B) Cryostat liver sections. On the top, hematoxylin and eosin stain is shown at a magnification of 25. Note the more intense infiltration of
liver from T cell–specific mutants with inflammatory cells 7 d after infection. On the bottom, immunostaining for CD4 (Hemalum counterstain) is
shown at a magnification of 100. Note the increased number of CD4  cells in mutant liver compared with the controls.T Cell–specific Inactivation of the IL-10 Gene 1294
ences in the numbers of infiltrating CD8  T cells or macro-
phages between mutants and controls (not depicted). Be-
cause the parasite load was low in both experimental groups,
there was no evidence for insufficient parasite control in
IL-10FL/FL CD4-Cre  mice.
IL-10 /  mice develop CD4  T cell–dependent lethal
immunopathology upon infection with T. gondii (5). Our
findings indicate that T cell–derived IL-10 normally pre-
vents lethal T. gondii–induced immunopathology in mice.
T Cell–specific IL-10 Mutants Display Enhanced Contact
Hypersensitivity Reactions. To analyze cutaneous T cell re-
sponses in animals with T cell–specific IL-10 deficiency,
we elicited contact hypersensitivity in IL-10FL/FL CD4-
Cre  mice and IL-10FL/FL Cre  littermates. Data presented
in Fig. 6 A show the ear swelling response after treatment
of ears with the contact allergen DNCB. The increase in
ear thickness was on average about twofold higher in IL-
10FL/FL CD4-Cre  compared with IL-10FL/FL Cre  mice at
all time points measured. The difference between mutants
and controls was highly significant (P   0.01 for 24, 48,
and 96 h; P   0.02 for 72 h; the standard deviation ob-
served was most likely due to mixed genetic backgrounds).
Thus, the T cell–mediated contact hypersensitivity reaction
is subject to regulation by T cell–derived IL-10. An en-
hanced ear swelling response, similar to the results obtained
for the T cell–specific IL-10 mutant, was observed for IL-
10D/D mice (Fig. 6 B), confirming published experiments
with IL-10 /  mice (8).
In Contrast to Complete IL-10 Deficiency, T Cell–specific IL-
10 Mutants Display a Normal Cutaneous Irritant Response.
The irritant response of the skin is a function of the local
innate immune system. To find out whether T cell–derived
IL-10 also regulates this type of inflammatory response, we
treated IL-10FL/FL CD4-Cre  mice and IL-10FL/FL Cre  lit-
termates with the irritant croton oil. The ear swelling re-
sponse in the T cell–specific IL-10 mutant mice was not
increased 24 and 48 h after croton oil application compared
with the control animals (Fig. 7 A), demonstrating that cu-
taneous innate inflammatory responses are not subject to
regulation by IL-10–producing T cells. In contrast, IL-10D/D
animals displayed significantly enhanced irritant responses
compared with IL-10–competent control mice (Fig. 7 B),
reproducing earlier findings in IL-10 /  mice (8). Thus,
the cutaneous irritant response is subject to regulation by
IL-10 secreted by cell types other than T cells.
In Contrast to Complete IL-10 Deficiency, T Cell–specific IL-
10 Mutants Do Not Display Increased Sensitivity to LPS. To
further analyze responses of the innate immune system, IL-
10 mutants were injected i.p. with LPS. None of the 10
IL-10FL/FL CD4-Cre  or the 10 Cre  littermates died after
LPS exposure (Fig. 8 A). Additional animals were bled 6 h
after LPS injection and serum concentrations of IFN- ,
TNF , and IL-12 were determined (Fig. 8 B). For IL-
10FL/FL CD4-Cre  mice, serum levels of these three cyto-
kines were in the same low range as those obtained for IL-
10–competent control animals, which produced little or no
IFN- , TNF , or IL-12. In contrast, 8 of 10 IL-10D/D, but
only 1 of 10 IL-10D/WT, littermates died within 3 d after
LPS injection (Fig. 8 A), consistent with a 20-fold in-
creased LPS sensitivity reported for IL-10    mice as com-
pared with WT controls (7). As expected, drastically in-
creased concentrations of IFN- , TNF , or IL-12 were
measured in the LPS-exposed IL-10D/D mice as compared
with IL-10–competent control animals (Fig. 8 B). Taken
together, these data show that T cell–derived IL-10 is not
involved in regulating the response to systemic LPS expo-
sure, but that this reaction is controlled by IL-10 from
non–T cells.
Figure 6. Contact hypersensitivity reactions of (A) IL-10FL/FL CD4-Cre 
(n   28) and IL-10FL/FL Cre  control mice (n   26), and (B) IL-10D/D
(n   28) and IL-10D/WT control mice (n   21). The increase in ear thick-
ness of sensitized mice was measured daily after challenge with DNCB.
Figure 7. Irritant response of (A) IL-10FL/FL CD4-Cre  (n   36) and
IL-10FL/FL Cre  control mice (n   35), and (B) IL-10D/D (n   17) and
IL-10D/WT control mice (n   16). The percent increase in ear thickness
was measured 24 and 48 h after application of croton oil.Roers et al. 1295
Discussion
Within the population of T cells, the capacity to secrete
IL-10 is well documented, in particular for Th2 cells and
some T cell subsets with regulatory function. T regulatory
cells have been shown to suppress immune responses by
IL-10–dependent or IL-10–independent mechanisms in
various experimental systems. IL-10–competent, but not
IL-10–deficient, CD4  CD25  CD45RBlo cells suppressed
development of IBD, resulting after adoptive transfer of
CD4  CD45RBhi cells into lymphocyte-deficient (SCID)
mice (29). Another subset of regulatory T cells, the T regu-
latory 1 cells, suppress immune responses through secretion
of large amounts of IL-10 (13, 32). In addition, transfer of
antigen-pulsed CD40-deficient myeloid dendritic cells in-
duced regulatory T cells, which suppressed T cell responses
by an IL-10–dependent mechanism (39). However, sup-
pression of T cell proliferation in response to polyclonal
stimulation by CD4  CD25  T regulatory cells in vitro re-
quires cell contact, but no IL-10 secretion (28). Likewise,
CD4  CD25  T cell–mediated suppression of autoimmune
gastritis induced by transfer of CD4  CD25  T cells into
lymphocyte-deficient (RAG-2 / ) recipients was indepen-
dent of IL-10 secretion (40, 41). Regulation of the priming
of potentially colitogenic T cells, however, by CD4 
CD25  T cells occurs primarily independent of IL-10 (30).
In vivo control of Leishmania major was shown to be regu-
lated by CD4  CD25  T cells through both IL-10–depen-
dent and IL-10–independent mechanisms (31). In addition
to T cells, a large number of other cell types are able to se-
crete IL-10. For example, IL-10–producing regulatory B
cells have been shown to prevent autoimmunity (16, 17).
Thus, the relevance of immune regulation mediated by T
cell–derived IL-10 in vivo remains unclear.
Our results show that T cell–specific IL-10 deficiency
results in a dysregulation of T cell–mediated immune re-
sponses, which is very similar to the phenotype observed
earlier in mice with complete IL-10 deficiency (2, 5, 8).
Like IL-10 /  animals, our T cell–specific IL-10 mutants
are susceptible to induction of IBD by environmental bac-
teria and exhibit severe immunopathology upon infection
with T. gondii as well as enhanced contact hypersensitivity
reactions. These results indicate that regulation of inflam-
matory responses by IL-10–producing T cells cannot be
substituted for by compensatory IL-10 production from
other cell types.
Intestinal inflammation in IL-10 /  mice is due to T
cell–dependent immunopathology as a result of an unbal-
anced Th1 cell response to luminal bacterial antigens (2).
Macrophages are a major source of IL-10 in the gut and se-
crete the cytokine in late phases of activation, for example
by abundant bacterial LPS to contain secretion of proin-
flammatory mediators in an autocrine fashion (10). Our re-
sults, however, show that IL-10–mediated autocrine-nega-
tive feedback of macrophages is insufficient to prevent
unbalanced immune responses in the intestine. Likewise,
IL-10 production by other intestinal cell types does not suf-
fice to compensate T cell–specific IL-10 deficiency.
Acute infection of IL-10 /  mice with an avirulent strain
of T. gondii results in a lethal CD4  T cell–mediated im-
mune response characterized by overproduction of TNF- ,
IFN- , and IL-12 (5). Production of IL-10 by macro-
phages in Toxoplasma infection is well documented (42,
43) and was considered a critical mechanism responsible for
controlling the Th1 cell response to T. gondii (5). How-
ever, our data show that in the absence of T cell–derived
IL-10, the lethal immune response occurs with similar ki-
netics as in IL-10 /  mice. This result demonstrates the
pivotal role IL-10–producing T cells play in the regulation
of T cell responses against microbial pathogens.
Contact hypersensitivity is a T cell–mediated immune
response that requires prior sensitization. IL-10 /  mice
show enhanced contact hypersensitivity reactions (8). Ker-
atinocytes, macrophages, dendritic cells, as well as T cells
are potential sources of IL-10 in the skin. The enhanced
contact hypersensitivity reactions in our T cell–specific IL-
10 mutant demonstrate that T cell–derived IL-10 is an im-
portant regulator of this type of T cell response.
In addition to unbalanced T cell responses resulting in
IBD, susceptibility to immunopathology upon infection,
and enhanced contact hypersensitivity reactions, IL-10 / 
mice also show an enhanced inflammatory response of the
skin to nonspecific irritation. This response is a T cell–inde-
pendent function of the innate immune system of the skin.
Interestingly, our T cell–specific IL-10 mutants did not ex-
hibit enhanced cutaneous irritant responses. Furthermore,
the T cell–specific IL-10 mutant mice did not exhibit exag-
gerated innate responses to systemic LPS exposure as deter-
mined by survival as well as production of TNF- , IFN- ,
and IL-12 after i.p. injection. Under defined experimental
Figure 8. Response of mice with complete or T cell–specific
IL-10 deficiency to LPS. 20  g of LPS/g body weight were
injected i.p. (A) Survival of IL-10FL/FL CD4-Cre  mice ( ,
n   10) and IL-10FL/FL Cre  control littermates ( , n   10),
and IL-10D/D animals ( , n   10) and IL-10D/WT control litter-
mates ( , n   10). (B) Additional animals were bled 6 h after
LPS injection and serum TNF- , IFN- , and IL-12 levels
were determined (symbols as in A).T Cell–specific Inactivation of the IL-10 Gene 1296
conditions, IL-10–secreting T cells were shown to regulate
intestinal innate inflammatory responses to Helicobacter hepat-
icus in lymphocyte-deficient mice (44). However, the en-
hanced sensitivity to endotoxic shock and cutaneous irrita-
tion observed in complete IL-10 deficiency are due to the
lack of IL-10 secretion from non–T cells like keratinocytes,
histiocytes, monocytes, or dendritic cells. Future experi-
ments will address this question by cell type–specific dele-
tion of the IL-10 gene in these cell types.
Dysregulation of T cell responses in our T cell–specific
IL-10 mutant may reflect the absence or functional impair-
ment of regulatory T cells, which depend on IL-10 for
their differentiation and/or their suppressive function. The
phenotype our mutant develops is unlikely to be a result of
the lack of the CD4  CD25  subset of T regulatory cells, as
absence of these cells in mice deficient for the transcription
factor foxp3 leads to a more severe disease with multior-
gan inflammation shortly after birth (25–27). In addition,
CD4  CD25  cells with suppressive activity are present in
IL-10 /  animals (28). Furthermore, foxp3 mRNA was
detectable in CD4  T cells sorted from suspensions of puri-
fied intestinal intraepithelial lymphocytes from all T cell–
specific IL-10 mutants analyzed (n   4) by real-time RT-
PCR (not depicted). As CD4  CD25  T regulatory cells
have been shown to mediate IL-10–dependent as well as
IL-10–independent effects (28–32), the phenotype of the T
cell–specific IL-10 mutant may result from a partial loss of
function of CD4  CD25  T regulatory cells. Analysis of
suppression of T cell proliferation in vitro, which repre-
sents a convenient assay for regulatory function, cannot
clarify this potential defect of the CD4  CD25  cells, as in
vitro suppression of T cell responses by these cells is known
to be independent of IL-10 (28).
Our data show that T cell–derived IL-10 is dispensable
for the regulation of cutaneous innate irritant responses, but
crucial for the regulation of T cell responses. We will ex-
pand the experiments presented here by crossing the condi-
tional IL-10–deficient mutation onto other Cre recombi-
nase–expressing mouse lines. By inactivating the IL-10
gene selectively in keratinocytes and macrophages, we hope
to identify the source of the IL-10–controlling cutaneous
innate responses. In addition, it will be of interest to ana-
lyze mice with cell type–specific deficiency for IL-10 in
macrophages, dendritic cells, intestinal epithelial cells, or
B cells for development of IBD or deregulation of T cell
responses. A further extension of our experiments will be
the cell type–specific inactivation of the IL-10 receptor to
identify the relevant IL-10–responsive cells.
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